“…Mab WM23 against GPIbα was obtained from Dr Michael Berndt (Baker Medical Research Institute, Prahan, Victoria, Australia). Mab GS28 against GS28 (a specific cis-Golgi marker) was purchased from StressGen Biotechnologies Corp. (Victoria, BC, Canada), Mab CTR 433 (against an uncharacterized marker of the medial Golgi) and Mab Gi93 [against ER-to-Golgi intermediate compartments (ERGIC) marker] were obtained from Dr Michel Bornens (Institut Curie, Paris, France), and a polyclonal antibody against calnexin (an ER marker) was purchased from Chemicon, Temecula, CA, U.S.A. CHO cell lines expressing wild-type GPIbα associated with GPIbβ and GPIX (CHOαβIX) or expressing Leu"(*-deleted GPIbα associated with GPIbβ and GPIX (CHOα∆LeuβIX) have been described previously [20].…”